NOAEL Studies
Cosmetic Ingredient
HC Blue No. 12 NOAEL Studies
INCI: HC BLUE NO. 12
CAS: 132885-85-9
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
SCCS Opinion 8 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =30 | mg/kg bw | rat | oral | 90-day | irritation | p.5 |
| SCCS Opinion | NOAEL | =140 | mg/kg bw | rat | dermal | 90-day | dermal absorption | p.5 |
| SCCS Opinion | NOAEL | =316 | mg/kg bw/d | - | - | 28 day | NOAEL study | p.18 |
| SCCS Opinion | NOAEL | =60 | mg/kg bw/d | rat | oral | 13 weeks | NOAEL study | p.19 |
| SCCS Opinion | NOAEL | =140 | mg/kg bw/d | human | - | developmental | developmental toxicity | p.27 |
| SCCS Opinion | NOAEL | =0.253 | mg/kg | rat | oral | 13-week | dermal absorption | p.29 |
| SCCS Opinion | NOAEL | =60 | mg/kg bw | rat | oral | 13-week | dermal absorption | p.29 |
| SCCS Opinion | NOAEL | =1668 | mg/kg bw | rat | - | 28 day | repeated dose toxicity | p.29 |
Regulatory source 14 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | - | 316 | mg/kg bw/d | - | - | 28 day | - | p.18 |
| Regulatory source | - | 60 | mg/kg bw/d | rat | oral | 13 weeks | - | p.19 |
| Regulatory source | dermal absorption | 140 | mg/kg bw | rat | dermal | 90-day | dermal absorption | p.5 |
| Regulatory source | dermal absorption | =0.253 | mg/kg | rat | oral | 13-week | dermal absorption | p.29 |
| Regulatory source | dermal absorption | =60 | mg/kg bw | rat | oral | 13-week | dermal absorption | p.29 |
| Regulatory source | developmental toxicity | 140 | mg/kg bw/d | human | - | developmental | developmental toxicity | p.27 |
| Regulatory source | irritation | 30 | mg/kg bw | rat | oral | 90-day | irritation | p.5 |
| Regulatory source | repeated dose toxicity | 60 | mg/kg bw/d | - | - | sub-chronic | repeated dose toxicity | p.20 |
| Regulatory source | repeated dose toxicity | 1668 | mg/kg bw | rat | - | 28 day | repeated dose toxicity | p.29 |
| Regulatory source | repeated dose toxicity | 60 | mg/kg bw/d | rat | - | 28 day | repeated dose toxicity | p.29 |
| Regulatory source | repeated dose toxicity | 140 | mg/kg bw/d | rat | - | 28 day | repeated dose toxicity | p.29 |
| Regulatory source | repeated dose toxicity | 1668 | mg/kg bw | rat | dermal | 28 day | repeated dose toxicity | p.29 |
| Regulatory source | repeated dose toxicity | 60 | mg/kg bw/d | rat | dermal | 28 day | repeated dose toxicity | p.29 |
| Regulatory source | repeated dose toxicity | 140 | mg/kg bw/d | rat | dermal | 28 day | repeated dose toxicity | p.29 |